Literature DB >> 23551575

Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.

Mohamed El-Shanshory1, Ibrahim Badraia, Amr Donia, Faten Abd El-Hameed, Mokhtar Mabrouk.   

Abstract

BACKGROUND: Pulmonary hypertension (PH) is an increasingly recognized life-threatening complication in sickle cell disease (SCD), with associated high mortality in adults. The prevalence of PH in children with SCD is still unknown. The etiology and pathophysiologic mechanisms are still not well understood. AIM OF THE STUDY: To assess the plasma levels of asymmetric dimethylarginine (ADMA) in children with SCD and its correlation with elevated tricuspid regurgitant jet velocity and other hemolytic markers. SUBJECTS &
METHODS: This study was carried out on a cohort of patients (30) with SCD and 30 healthy children as a control group. Certain investigations were carried out for all subjects: CBC, lactate dehydrogenase (LDH), ferritin, reticulocytic count, bilirubin, AST, ALT, and plasma levels of ADMA. Doppler echocardiography was carried out for all subjects.
RESULTS: The prevalence of high tricuspid regurgitant velocity (TRV) was 30% in SCD patients. ADMA mean plasma level was significantly higher in patients than in controls (0.79 ± 0.15 μmol/L and 0.46 ± 0.11 μmol/L, respectively, P < 0.001). ADMA was significantly higher in patients with high TRV than those with normal TRV (1.10 ± 0.11 μmol/L, 0.80 ± 0.06 μmol/L, respectively, P < 0.001). There was a significant positive correlation between ADMA plasma levels and TRV ≥2.5 m/s (r = 0.475).
CONCLUSION: High plasma ADMA levels may be implicated in the pathogenesis of increased tricuspid regurgitant jet velocity in children with SCD.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551575     DOI: 10.1111/ejh.12114

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  5 in total

1.  Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.

Authors:  Zhen-fei Fang; Yi-yuan Huang; Liang Tang; Xin-qun Hu; Xiang-qian Shen; Jian-jun Tang; Sheng-hua Zhou
Journal:  Pediatr Cardiol       Date:  2015-03-04       Impact factor: 1.655

2.  Endothelial dysfunction biomarkers in sickle cell disease: is there a role for ADMA and PAI-1?

Authors:  Suellen Rodrigues Martins; Sílvia Letícia de Oliveira Toledo; Aislander Junio da Silva; Fernanda Santos Mendes; Marina Mendes de Oliveira; Leticia Gonçalves Resende Ferreira; Luci Maria Sant'Ana Dusse; Maria das Graças Carvalho; Danyelle Romana Alves Rios; Patrícia Nessralla Alpoim; Melina de Barros Pinheiro
Journal:  Ann Hematol       Date:  2021-10-19       Impact factor: 3.673

Review 3.  Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship.

Authors:  Rayan Bou-Fakhredin; Lucia De Franceschi; Irene Motta; Assaad A Eid; Ali T Taher; Maria Domenica Cappellini
Journal:  Antioxidants (Basel)       Date:  2022-05-13

4.  Asymmetric Dimethylarginine Levels and Its Correlation to Cerebral Blood Flow in Children with Sickle Cell Anemia.

Authors:  Mohamed El-Shanshory; Nahed Hablas; Hala Nagy; Naglaa Fathy
Journal:  Indian J Hematol Blood Transfus       Date:  2019-03-13       Impact factor: 0.900

Review 5.  Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate.

Authors:  Kelley L Colvin; Melanie J Dufva; Ryan P Delaney; D Dunbar Ivy; Kurt R Stenmark; Michael E Yeager
Journal:  Front Pediatr       Date:  2014-02-03       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.